Terms: = Lung cancer AND HOXD11, ENSG00000128713, 3237 AND Treatment
4 results:
1. A graded prognostic model for patients surviving 3 years or more (GPM ≥ 3Ys) after stereotactic radiosurgery for brain metastasis.
Sato Y; Yamamoto M; Serizawa T; Yamada KI; Higuchi Y; Kasuya H
Radiother Oncol; 2021 Mar; 156():29-35. PubMed ID: 33249092
[TBL] [Abstract] [Full Text] [Related]
2. CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome.
Ortolan E; Giacomino A; Martinetto F; Morone S; Lo Buono N; Ferrero E; Scagliotti G; Novello S; Orecchia S; Ruffini E; Rapa I; Righi L; Volante M; Funaro A
Oncotarget; 2014 Aug; 5(15):6191-205. PubMed ID: 25026285
[TBL] [Abstract] [Full Text] [Related]
3. How should cancer presenting as a malignant pleural effusion be managed?
Bonnefoi H; Smith IE
Br J Cancer; 1996 Sep; 74(5):832-5. PubMed ID: 8795590
[TBL] [Abstract] [Full Text] [Related]
4. Validation of somatostatin receptor scintigraphy in the localization of neuroendocrine tumors.
Lamberts SW; Reubi JC; Krenning EP
Acta Oncol; 1993; 32(2):167-70. PubMed ID: 8391830
[TBL] [Abstract] [Full Text] [Related]
